 | Study programme 2025-2026 | Français | |
| Aspects toxicologiques et délivrance | |||
Learning Activity |
| Code | Lecturer(s) | Associate Lecturer(s) | Subsitute Lecturer(s) et other(s) | Establishment |
|---|---|---|---|---|
| M-PCLI-091 |
|
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term |
|---|---|---|---|---|---|---|---|
| Français | Français | 10 | 0 | 0 | 0 | 0 | Q1 |
Content of Learning Activity
The objective of this learning activity is
- that the student adopts an approach aimed at limiting drug cascades,
- that he detects drug-induced iatrogenic events and takes measures to limit them
- that he adopts the appropriate measures : notifications to pharmacovigilance, consultation of risk management plans, contact with the prescribing physician, etc.
The detection of adverse effects will be approached on the basis of common complaints encountered in pharmacies (in the form of clinical cases or lectures). Students' attention will be drawn to the drugs most at risk of exhibiting toxicity, for example drugs with a short therapeutic-toxic index and anticancer drugs ...
Some pharmacological classes will be addressed more specifically: NSAIDs, corticosteroids, proton pump inhibitors ...
1. Introduction
2. Pharmacovigilance
3. Plaints with drug origins (including due to drug interactions)
4. Toxicity in oncology
5. Drug hypersensitivity
6. Excipients with known effects
7. Risk management plan
Required Learning Resources/Tools
Documents on Moodle
https://www.cbip.be/fr/chapters
Recommended Learning Resources/Tools
Not applicable
Other Recommended Reading
Not applicable
Mode of delivery
- Face-to-face
Type of Teaching Activity/Activities
- Cours magistraux
Evaluations
The assessment methods of the Learning Activity (AA) are specified in the course description of the corresponding Educational Component (UE)
Location of learning activity
- Université de Mons - Mons
Location of assessment
- Université de Mons - Mons